Practical application of bioinformatics by the multidisciplinary VIZIER consortium

Area of Science:

• Bioinformatics
• Virology
• Structural Genomics

Background:

• RNA viruses, including HIV, Influenza, and Hepatitis C, pose significant threats to human and animal health.
• Emerging and re-emerging viral infections necessitate the development of broad-spectrum antiviral therapies.
• The VIZIER consortium aimed to address the challenge of developing antiviral drugs against diverse RNA virus lineages.

Purpose of the Study:

• To review the bioinformatics technologies applied by the VIZIER consortium.
• To demonstrate how these technologies supported the project's objectives in comparative structural genomics of viral enzymes.
• To highlight the role of bioinformatics in advancing antiviral drug discovery.

Main Methods:

• Bioinformatics-mediated selection of RNA viruses.
• Prediction of viral protein targets for drug development.
• Analysis of 3D protein structures and antiviral compound interactions.
• Information flow management within a multidisciplinary consortium.

Main Results:

• Bioinformatics technologies provided integrated solutions for project advancement.
• Facilitated the identification and validation of numerous RNA virus targets.
• Enabled a comprehensive approach to antiviral therapy development.
• Established a communication framework for complex research endeavors.

Conclusions:

• The VIZIER project successfully leveraged bioinformatics for RNA virus target identification.
• The applied technologies were crucial for the timely advancement of antiviral research.
• This multidisciplinary approach is vital for developing a robust pipeline of antiviral drugs.